Smuary Tumour necrosis factor a (TNF-a) is a cytokine with a variety of immunological properties. The identification of two receptors for this molecule, i.e. the 75 kDa and the 55 kDa TNF receptors (TNF-R), recently clarified the mechanisms through which this cytokine provides its wide range of immunomodulatory activities. In this study we Tumour-infiltrating lymphocytes (TILs) have been extensively studied over the last few years both in vitro and in vivo for their potent anti-tumour activity (Itoh et al., 1986; Muul et al., 1987; Rosenberg et al., 1988; Kradin et al., 1989) . It has been demonstrated that they might control tumour growth by mediating a large spectrum of functional activities including cytotoxicity, cytokine release, helper and suppressor activities or a combination of these effects (Itoh et al., 1986; Topalian et al., 1989; Balch et al., 1990; Kim et al., 1990; Pandolfi et al., 1991) . Human TILs have been derived from a variety of solid tumours in the presence of several cytokines, including inter}eukcin 2 (IL-2) and interleukin 4 (IL-4). Although many data are now available regarding the ability of TILs to control tumour growth, the mechanisms accounting for their in vitro and possibly in vivo proliferation are still largely unknown (Kawakami et al., 1988; Yagita et al., 1989; Shimuzu et al., 1991) .
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TNF-a provides a wide spectrum of immunoregulatory activities on several cell types, including B, T and NK lym- phocytes, monocytes and polymorphonuclear cels (Shalaby et al., 1985; Philip and Epstein, 1986; Ostensen et al., 1987; Ranges et al., 1987; Blay et al., 1989) . Among these, TNF-e has been observed to play a role in T-cell proliferation (Nedwin et al., 1985; Scheurich et al., 1987; Robinet et al., 1990) , thus providing a co-stimulatory proliferative signal. The production of TNF-x and the expression of its specific receptors may be regulated by IL-2. The finding that these cytokines (TNF-a and IL-2) have synergistic effects on T-cell proliferation (Scheurich et al., 1987) suggests that TNF-a may function as an autocrine/paracrine growth factor for T cells. TNF-( mediates its biological activity through two specific membrane receptors, which have been recently identified and cloned: type 1 TNF-R of 55-60 kDa and type 2 TNF-R of 75-80kDa (Imamura et al., 1988; Gray et al., 1990; Kohno et al., 1990; Loetscher et al., 1990; Schall et al., 1990; Smith et al., 1990; Lewis et al., 1991 (1990) . The following MAbs were used; the utr-I and the htr-9 MAbs (Brockhaus et al., 1990) (kindly provided in PBS buffer by Dr M Brockhaus, Basle, Switzerland) which recognise the 75 kDa and 55 kDa TNF-R, respectively, and followed by an incubation with F(ab)2 goat anti-mouse (Technogenetics, Turin, Italy), as previously described . Both antibodies have previously been observed to work in different experimental conditions, including on B, T and granular lymphocytes (Zambello et al., 1992; Trentin et al., 1993) . Controls for flow cytometric analysis were performed using isotype control antibodies.
The expression of TNF receptors on TILs was also investigated by evaluating the binding of phycoerythrin (PE)-TNF-x on the cell surface using a flow cytometer. Briefly, 10g±l of PE-TNF-x (10Lg ml-') was added to 10' cells and the mixture was incubated for 60 min on ice. Cells were then washed twice and resuspended in 0.2 ml of PBS for flow cytometric analysis. As controls for the FACS analysis, cells were incubated with avidin-PE. The TNFa assay The presewne of TNF-x in the 13 culture supernatants of cells grown at a concentration of 1 x IOml-' in 24-well plates in the presence of IL-2 (l00Uml-') and 14-18 days after the restimulation was analysed using an immunoenzymatic assay. This was based on two mouse non-cross-reacting IgGl MAbs (B154.9 and B154.7, kindly provided by Dr G Trinchieri, the Wistar Institute, Philadelphia, PA, USA) (Cuturi et al., 1987) , directed against two distin determinants of TNF-a. One of these (B154.7 MAb) was coupled to alkalin phosphatase according to standard protocols. An enzyme-linked immunosorbent assay (ELISA) amplfication system (Immuno Sekct, Gibco BRL) was also used to enhance the TNF-x detection limit, which in the final assay was 50 pg ml-'. Data are expressed as mean ± s.d.
Res
The data of the phenotypic analysis are reported in Table I trations of IL-2 (c.p.m. 16 500 ± 1208, 48 320 ± 6240, 56 430 ± 3480 at 10, 100 and 1000 U ml-' IL-2, respectively). These data are consistent with the phenotypic findings that these cells are equipped with a high-affinity IL-2R complex (Trentin et al., 1994) . When TIL lines were grown in the presence of different concentrations of IL-2 and anti-TNF-a antibodies (Figure 3) Wang et al., 1989; Vaccarello et al., 1990; Ioannides et al., 1992) and this cytokine has been demonstrated to potentiate the lytic machinery of cytotoxic cells (Ostensen et al., 1987; Ranges et al., 1987; Espevik et al., 1988; Blay et al., 1989; Naume et al., 1991) To address the question of the specific surface structures involved in the transduction of the proliferative signal by endogenously produced TNF-m, TILs were evaluated for the presence of different TNF-Rs using MAbs that specifically recognise TNF receptors. Our results demonstrate that the 75 kDa TNF-R is expressed on the surface membrane of freshly isolated and cultured TILs, while the 55 kDa TNF-R was lacking on the same cells. In addition, the anti-75 kDa TNF-R antibody has been shown to affect the binding of PE-TNF-(. In view of the consideration that TNF-x induces a wide spectrum of activities, it is likely that some of these functions are independently mediated by one of the two receptors. In fact, the 55 kDa TNF-R has been observed to trigger cytotoxicity, the proliferation of fibroblasts and the synthesis of prostaglandin E2, while the 75 kDa TNF-R delivers the signal for T-cell proliferation (Englemann et al., 1990; Espevik et al., 1990; Tartaglia et al., 1991) . Our observation that anti-75 kDa TNF-R antibody inhibits TIL proliferation suggests that this structure is involved in the in vitro TIL growth.
Our finding that TIL lines and freshly isolated TILs grow in the presence of IL-2 and express functional TNF receptors suggests that IL-2 might up-regulate the expression of this receptor, similar to what has been observed on cultured T cells obtained from peripheral blood (Ware et al., 1991) . The evidence that TNF-a up-regulates the expression of IL-2 receptors (Scheurich et al., 1987; Chouaib et al., 1988) indicates that the expression of these receptors (both IL-2 and TNF receptors) and the effect of these cytokines on T cells are likely to be closely related.
In as much as it has been extensively reported that TNF-a exhibits cytotoxic effects, the possible role of this cytokine in the control of tumour growth in neoplastic patients deserves comment. Results reported in this manuscript coupled with the observation that TILs release TNF-a following autologous tumour stimulation (Schwartzentruber et al., 1991) highlight the role of this cytokine on the mechanism leading to the expansion and function of TILs. Moreover, the therapeutic efficacy of these cells on clinical grounds might be related to the role of TNF-a not only via a direct cytotoxic mechanism but also favouring the accumulation of relevant T-cell subsets at the site of tumour growth in vivo.
Abhrvistiom: TIL, tumour-infiltratig lymphocyte; TNF-o, tumour necrosis factor a, TNF-R, tumour necrosis factor receptor, PBL, peripheral blood lymphocyte; PE, phycoerythrin.
